Cardiology trials continue to under-represent certain population groups relative to disease distribution; this Perspective outlines strategies to foster representativeness and create a research enterprise that meets the needs of people living with cardiovascular disease.
- Faiez Zannad
- Otavio Berwanger
- Harriette G. C. Van Spall